Basic Information
ID: ALA5098550
Type: Functional
Description: Agonist activity at recombinant human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation by measuring maximum efficacy preincubated for 15 mins followed by forskolin stimulation and measured after 15 mins by HTRF assay relative to control
Organism: Homo sapiens
Cell type: CHO
Activity Charts
Bioactivity
Activity Types for Assay ALA5098550
Emax
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 376.58 | 5.66 | 5.66 |
| 414.63 | 6.63 | 6.63 |
| 306.52 | ||
| 320.55 | ||
| 334.58 | ||
| 334.58 | ||
| 374.60 | ||
| 306.52 | ||
| 320.55 | ||
| 398.62 | ||
| 334.58 | ||
| 402.65 | ||
| 402.65 | ||
| 330.54 | ||
| 354.57 | ||
| 402.65 | ||
| 358.60 | ||
| 358.60 | ||
| 370.57 | ||
| 362.63 | ||
| 382.62 | ||
| 320.55 | ||
| 348.60 | ||
| 386.65 | ||
| 430.71 | ||
| 348.60 | ||
| 386.65 | ||
| 292.50 |